Biotechnology News

November 14, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, today publishes the major key...

November 14, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc. (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid antisense cancer drugs, today announced that it has completed treatment of the...

November 14, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega celebrates the grand opening of a new facility for its China operations that includes molecular biology reagent production, research, development and cGMP manufacturing capabilities.

November 14, 2012

PARIS & LONDON--(BUSINESS WIRE)--Forxiga™ (dapagliflozin), First-In-Class SGLT2 That Works Independently of Insulin, Now Approved in European Union for Treatment of Type 2 Diabetes

November 14, 2012

PRINCETON, N.J. and LONDON--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the European Commission has approved Forxiga™ (dapagliflozin) tablets for the treatment of type 2 diabetes in...

November 14, 2012

ZURICH & HAMBURG, Germany--(BUSINESS WIRE)--BIO-Europe® 2012 hosted over 3,000 life science leaders to Hamburg, Germany November 12–14

November 14, 2012

KERRVILLE, Texas--(BUSINESS WIRE)--Solace Lifesciences, the creators of NuCalm®, announced today that NuCalm has been successfully used by over 100,000 dental patients across the United States since its commercial release in Sept, 2010

November 14, 2012

MORRISTOWN, N.J & CHICAGO--(BUSINESS WIRE)--Biopharmaceutical company Durata Therapeutics is moving its corporate headquarters to Chicago from NJ, the reverse of a trend of Midwest startups moving to the East or West Coast.

November 14, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics Announces New Strategic Partnership with Mexico-Based Company, Pharmacos Exakta, S.A. de C.V.

November 14, 2012

WILMINGTON, N.C., & NEWTON, Mass.--(BUSINESS WIRE)--PPD Signs Agreement to use Tessella and Berry Consultants’ Adaptive Trial Design Software

November 14, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using...

November 14, 2012

DAVIS, Calif.--(BUSINESS WIRE)--GSD’s portfolio of parasite tests provides laboratories with a reliable, single-source procurement option and access to a wide range of serological and stool assays

November 14, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Recent study shows centralized medical information teams better serve as internal knowledge resource centers.

November 14, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences have announced the launch of LifeMap BioReagents™ (http://...

November 14, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Arrayit Corporation (OTCQB: ARYC) (“ARYC”) is pleased to announce that Arrayit Diagnostics, Inc. (“AD”) has filed an S-1 registration statement with the Securities and Exchange Commission today. Upon the...

November 14, 2012

ATLANTA--(BUSINESS WIRE)--Liaison Healthcare, a global provider of cloud-based integration and data management services announces that 4 out of the top 5 pharmaceutical companies leverage their solutions for harmonizing data.

November 14, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems has been issued two new U.S. patents related to the Company's direct detection technology, T2MR.

November 14, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that although biologic use is much lower among SLE patients compared to other immune...

November 14, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Foundation’s Together on Diabetes™ Marks World Diabetes Day with Second Annual Report and Two New Grants in India

November 14, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. successfully completes a Phase I first-in-human clinical trial of TRV130, a biased ligand at the mu-opioid receptor, and potential intravenous treatment for severe post-operative pain.

November 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9 Announces Winners of Inaugural G-Prize Contest; Awardees to receive custom designed DNA for groundbreaking projects that will propel the synthetic biology field forward

November 14, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology Reports third Quarter 2012 Financial Results

November 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron's dalantercept (ACE-041) enters Phase 2 clinical trial for endometrial cancer in collaboration with the Gynecologic Oncology Group

November 14, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Dendreon Corporation (NASDAQ: DNDN) today announced the appointment of Lindsay Rocco as executive vice president, corporate communications and member of the executive committee, effective immediately. In this...

November 14, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that it has entered into a definitive agreement to acquire Cypress...

November 14, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its annual report on Form...

November 14, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced that it has appointed Christina Waters, Ph.D., as Chief Development and Marketing Officer.

November 14, 2012

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Millipore Employee Martha Rook receives Silver Stevie Women in Business Award for her innovative work in stem-cell scale-up production

November 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) , a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with an RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for...

November 14, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical will exhibit the benefits of biomedical textile engineering as a technology platform for device design at the BIOMEDevice Exposition and Conference in San Jose, CA on December 4-5.

November 14, 2012

GLASGOW, United Kingdom--(BUSINESS WIRE)--MSD, known as Merck in the United States and Canada, today presented new data from a post-hoc, subgroup analysis of three double-blind clinical trials, which found ISENTRESS® (raltegravir) demonstrated...

November 14, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted...

November 14, 2012

SAN FRANCISCO--(BUSINESS WIRE)--CollabRx, Inc. today announced financial results for the Second Quarter Fiscal Year 2013, which ended September 30, 2012.

November 14, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that its President and Chief Executive Officer, Dr. Anat Cohen-Dayag, will be presenting at the Jefferies 2012 Global Healthcare Conference in London on Thursday,...

November 14, 2012

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2012. Highlights of the Third Quarter of 2012 and Recent...

November 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced that Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the Piper Jaffray 24th Annual Healthcare Conference. The...

November 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Piper Jaffray Healthcare Conference in New York, New York on November 28, 2012. The live webcast is scheduled to begin...

November 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported the financial results for...

November 14, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Scouts New Biotech Innovations at NIBA Investment Conference

November 14, 2012

MUNICH--(BUSINESS WIRE)--Only weeks after the release of Buzz™—the newest Brainlab innovation for the digital operating suite—Brainlab announced today a watershed agreement with the Großhadern Clinic branch of the Hospital of the University of...

November 14, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards (FPC)(STO:FINGB) has opened its first US-based sales- and support office in San Francisco, California, and hired Charles Ng as Sales Director North America. Charles previous employer...

November 14, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies, (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today the launch of its third Viaskin programme in the...

November 13, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission

November 13, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 2012 Credit Suisse Healthcare Conference in Phoenix. John F. Milligan, PhD, Gilead’s President and...

November 13, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals third quarter 2012 financial results

November 13, 2012

INDIANAPOLIS--(BUSINESS WIRE)--YourEncore today launched a new solution that will help pharmaceutical companies make more informed decisions about whether and how to proceed with Phase III trials.

November 13, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from PALACE-1, the Company’s first Phase III study in psoriatic arthritis, at the American College of...

November 13, 2012

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix (OTC Markets: NNLX) is the subject of a featured news article released last week by the US Environmental Protection Agency. The article covers the progress of an ongoing Cooperative Research and...